Pharma companies need to limit the presence of nitrosamines in human medicines: EMA
Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » European Commission
Browsing Tag
European Commission
Global COVID-19 fundraising meeting raises $6.9 billion, leaders want vaccine for all
The money will be used for COVID-19 tests, treatments and vaccines, and also to support the world’s poorest and most…